EDWIN GUZMAN: Open Payments
NPI 1881290252 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,456 in 113 payments from 12 companies in 2025. Trend: 2023 $60 · 2024 $1,525 · 2025 $2,456
Food & beverage: $2,344Education: $112
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $485 |
| Incyte Corporation | 20 | $472 |
| Arcutis Biotherapeutics, Inc. | 40 | $460 |
| ABBVIE INC. | 10 | $367 |
| Organon LLC | 10 | $285 |
| GENZYME CORPORATION | 5 | $142 |
| Verrica Pharmaceuticals Inc. | 3 | $66 |
| Galderma Laboratories, L.P. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| UCB, Inc. | 1 | $35 |
Products named: TREMFYA, OPZELURA, Zoryve, SKYRIZI, VTAMA, DUPIXENT, RINVOQ, YCANTH.
Industry payments across CA — which companies pay providers there.
